- Fund Type: SICAV
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
BlackRock Global Funds - World Healthscience Fund
+ Add to WatchlistERDV:GR
18.1800 EUR 0.0100 0.06%As of 09:00:40 ET on 05/22/2013.
Snapshot for BlackRock Global Funds - World Healthscience Fund (ERDV)
| Open: | 18.1900 | High - Low: | 18.2470 - 17.9400 | Primary Exchange: | Berlin |
|---|---|---|---|---|---|
| Volume: | 549 | 52-Week Range: | 13.0800 - 18.4600 | Beta vs NDWUHC: | 0.8395 |
Fund Profile & Information for ERDV
BlackRock Global Funds - World Healthscience Fund is an open-end Fund incorporated in Luxembourg. The Fund's objective is to maximize growth in United States dollars. The Fund invests globally in equities of companies with substantial interests in healthcare, pharmaceuticals and medical technology and supplies.
| Inception Date: | 2001-04-06 | Telephone: | 352-34-20-101 |
|---|---|---|---|
| Managers: | THOMAS P CALLAN | ||
| Web Site: | www.blackrockinternational.com | ||
Fundamentals for ERDV
| NAV | (on 2013-05-17) 18.1900 |
|---|---|
| Assets (M) | (on 2013-04-30) 950.9429 |
| Shares out (M) | 0.00 |
| Market Cap (M) | 0.00 |
| % Premium | -0.44 |
| Average 52-Week % Premium | -0.1063 |
| Fund Leveraged | N |
Dividends for ERDV
No dividends reported
Performance for ERDV
| 1-Month | +5.21% | 1-Year | +35.80% |
|---|---|---|---|
| 3-Month | +17.00% | 3-Year | +17.73% |
| Year To Date | +26.71% | 5-Year | +15.33% |
| Expense Ratio | 1.84 |
Top Fund Holdings for ERDV
Filing Date: 03/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Gilead Sciences Inc | 700,386 | 34,269,887 | 4.518% |
| Novartis AG | 474,500 | 33,798,009 | 4.456% |
| Johnson & Johnson | 412,500 | 33,631,125 | 4.434% |
| Roche Holding AG | 129,700 | 30,269,497 | 3.991% |
| Celgene Corp | 254,690 | 29,521,118 | 3.892% |
| Amgen Inc | 262,700 | 26,929,377 | 3.550% |
| Bristol-Myers Squibb Co | 611,900 | 25,204,161 | 3.323% |
| Eli Lilly & Co | 398,500 | 22,630,815 | 2.984% |
| Sanofi | 221,800 | 22,577,157 | 2.976% |
| AbbVie Inc | 486,000 | 19,819,080 | 2.613% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page